Good news for BIEL Longs
* Our COB Dr. Staelin attended yesterday's webinar, said he was there to confirm everything said was consistent with the BIEL/Electrome agreement
* Ken was joined by dr. Nev Zubcevik and PhD Erik A. Nilsen, Nev said they were a few weeks out from DARPA use for Musculoskeletal and Neurodegeneration
* Long time BIEL investor and Electrome adviser Nigel Timothy attended and had several questions for Ken
* Ken indicated that in addition to the US market, Canada was also in the BIEL agreement
* Electrome has current ongoing research at Harvard (Brain), Tulane (Lime), Boston univ (Melanoma)
* The VA in Huston is one of the first institutions to adopt the Electrome platform
Market Data 
Markets 
